Atlas Trials

A Study of TAK-861 in Participants With Narcolepsy Type 2

Clinical trial NCT05687916 · COMPLETED

Trial details

NCT number
NCT05687916
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Narcolepsy Type 2
Start date
2023-01-09
Primary completion
2023-12-13
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.